Advertisement

Experientia

, Volume 30, Issue 6, pp 640–641 | Cite as

Cerebrospinal fluid 5-hydroxyindoleacetic acid level in migrainous patients during spontaneous attacks, during headache-free periods and following treatment withl-tryptophan

  • M. Poloni
  • G. Nappi
  • A. Arrigo
  • F. Savoldi
Specialia

Keywords

Cerebrospinal Fluid Acid Level Periodo Migrainous Patient Spontaneous Attack 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Riassunto

La concentrazione di acido 5-idrossindolacetico nel liquor lombare di pazienti emicranici diminuisce lievemente e non significativamente durante l'attacco, mentre, in periodo intercritico, non è diversa da quella osservata nei soggetti normali. La somministrazione dil-triptofano porta costantemente ad un incremento dei livelli di acido 5-idrossindolacetico nel liquor lombare di soggetti emicranici, oltre ad esercitare un'azione preventiva degli accessi di cefalea.

Literatur

  1. 1.
    F. Sicuteri, A. Testi andB. Anselmi, Int. Arch. Allerg.19, 55 (1961).Google Scholar
  2. 2.
    D. A. Curran, H. Hinterberger andJ. W. Lance, Brain88, 997 (1965).PubMedGoogle Scholar
  3. 3.
    G. Curzon, P. Theaker andB. Phillips, J. Neurol. Neurosurg. Psychiat.29, 85 (1966).PubMedGoogle Scholar
  4. 4.
    M. Anthony, H. Hinterberger andJ. W. Lance, Arch. Neurol.16, 544 (1967).PubMedGoogle Scholar
  5. 5.
    M. Anthony andJ. W. Lance, Arch. Neurol.25, 225 (1971).PubMedGoogle Scholar
  6. 6.
    M. Anthony, Hemicrania4, 1 (1972).Google Scholar
  7. 7.
    M. Anthony, Excerpta med.296, 91 (1973).Google Scholar
  8. 8.
    F. Sicuteri, B. Anselmi andP. L. DelBianco, Psychopharmacology29, 347 (1973).CrossRefGoogle Scholar
  9. 9.
    A. L. Southren andN. Christoff, J. Lab. clin. Med.59, 320 (1962).PubMedGoogle Scholar
  10. 10.
    M. Barrie andA. Jowett, Brain90, 785 (1967).PubMedGoogle Scholar
  11. 11.
    P. Kangasniemi, V. Sonninen andU. K. Rinne, Headache12, 62 (1972).CrossRefPubMedGoogle Scholar
  12. 12.
    G. W. Aschcroft andD. F. Sharman, Br. J. Pharmac.19, 153 (1962).Google Scholar
  13. 13.
    D. Eccleston, D. W. Aschcroft, T. B. B. Crawford, J. B. Stanton, D. Wood andP. H. MacTurk, J. Neurol. Neurosurg. Psychiat.33, 269 (1970).PubMedGoogle Scholar
  14. 14.
    D. L. Dunner andF. K. Goodwin, Arch. gen. Psychiat.26, 364 (1972).PubMedGoogle Scholar
  15. 15.
    R. W. Kimball, A. P. Friedman andE. Vallejo, Neurology10, 107 (1970).Google Scholar

Copyright information

© Birkhäuser Verlag 1974

Authors and Affiliations

  • M. Poloni
    • 1
  • G. Nappi
    • 1
  • A. Arrigo
    • 1
  • F. Savoldi
    • 1
  1. 1.Clinica delle Malattie Nervose e Mentali dell' UniversitàPavia(Italy)

Personalised recommendations